Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the..
Ending weeks of speculation, BJP national vice-president Mukul Roy, along with his son and former MLA Subhrangshu, returned to the ruling Trinamool fold on Friday; Poll strategist Prashant Kishor met..
A day after Prime Minister Narendra Modi capped the service charge of vaccines administered by private hospitals at Rs 150, the Centre on Tuesday fixed the maximum price for Covid vaccines to be given..
Twelve major opposition parties have written to Prime Minister Narendra Modi. The Delhi government has said that People under the age of 45 won't get shots of Covaxin from tomorrow with limited stocks..
Speaking on COVID-19 situation in Maharashtra, State Health Minister Rajesh Tope on May 04 said, "Few centres were closed yesterday due to doses' shortage. Got 9 lakh vials today, to last for 2-3 days...
While it must be understood that taking both doses of any vaccine whether it be Covishield, Covaxin or Sputnik, the ones that are available in India, are critical, here is what we know about one dose..
Delhi Chief Minister Arvind Kejriwal on Friday appealed to people in the 18-44 age group not to queue up outside COVID vaccination centres from May 1, saying Delhi hasn't yet received vaccine doses. In..
Credit: HT Digital Content Duration: 03:45Published
People of Madhya Pradesh will have to wait for few more days as state Chief Minister Shivraj Singh Chouhan informed that vaccine manufacturers won't be able to deliver vaccine doses on May 01. "We had..
Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month. Zee News - Published
Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee.. IndiaTimes - Published Also reported by •Zee News
Though the Sputnik vaccine has arrived in Mumbai, it wasn’t administered on Thursday. Out of total 43,26,427 doses administered till date, 3,09,702 were Covaxin and 907 were Sputnik, the rest were.. Mid-Day - Published
Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of interest (EoI) for the inactivated.. IndiaTimes - Published
Bharat Biotech’s US partner Ocugen Inc has entered into a partnership with Jubilant HollisterStier LLC, a step-down subsidiary of Jubilant Pharmova, for the manufacture of indigenously developed.. IndiaTimes - Published
The indigenously developed Covaxin does not contain newborn calf serum, clarified Centre on Wednesday. The statement came in response to some social media posts which the government said have "twisted.. IndiaTimes - Published
Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals.. IndiaTimes - Published
Paytm will now allow users to book vaccination slots at the nearest vaccine center via its platform. While the company introduced Vaccine Finder on the app in May to help users look for available COVID.. BGR India - Published